These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23613976)

  • 41. Factors for incomplete adherence to antiretroviral therapy including drug refill and clinic visits among older adults living with human immunodeficiency virus - cross-sectional study in South Africa.
    Barry A; Ford N; El-Khatib Z
    Trop Med Int Health; 2018 Mar; 23(3):270-278. PubMed ID: 29243867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Facilitators and barriers to antiretroviral therapy adherence among HIV-positive adolescents living in Tanzania.
    Audi C; Jahanpour O; Antelman G; Guay L; Rutaihwa M; van de Ven R; Woelk G; Baird SJ
    BMC Public Health; 2021 Dec; 21(1):2274. PubMed ID: 34903209
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
    Inzaule SC; Hamers RL; Kityo C; Rinke de Wit TF; Roura M
    PLoS One; 2016; 11(11):e0167492. PubMed ID: 27898736
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Barriers to and facilitators of adherence to pediatric antiretroviral therapy in a sub-Saharan setting: insights from a qualitative study.
    Fetzer BC; Mupenda B; Lusiama J; Kitetele F; Golin C; Behets F
    AIDS Patient Care STDS; 2011 Oct; 25(10):611-21. PubMed ID: 21823909
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 'I saw it as a second chance': A qualitative exploration of experiences of treatment failure and regimen change among people living with HIV on second- and third-line antiretroviral therapy in Kenya, Malawi and Mozambique.
    Burns R; Borges J; Blasco P; Vandenbulcke A; Mukui I; Magalasi D; Molfino L; Manuel R; Schramm B; Wringe A
    Glob Public Health; 2019 Aug; 14(8):1112-1124. PubMed ID: 30632883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 'Blood pressure can kill you tomorrow, but HIV gives you time': illness perceptions and treatment experiences among Malawian individuals living with HIV and hypertension.
    Hing M; Hoffman RM; Seleman J; Chibwana F; Kahn D; Moucheraud C
    Health Policy Plan; 2019 Nov; 34(Supplement_2):ii36-ii44. PubMed ID: 31723966
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Understanding the facilitators and barriers of antiretroviral adherence in Peru: a qualitative study.
    Curioso WH; Kepka D; Cabello R; Segura P; Kurth AE
    BMC Public Health; 2010 Jan; 10():13. PubMed ID: 20070889
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs.
    Fleming T; Collins AB; Bardwell G; Fowler A; Boyd J; Milloy MJ; Small W; McNeil R
    PLoS One; 2021; 16(2):e0246999. PubMed ID: 33635886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "I want to be healthy and move on": A qualitative study of barriers and facilitators to antiretroviral treatment adherence among young adult survivors with perinatal HIV in Thailand.
    Aurpibul L; Tangmunkongvorakul A; Detsakunathiwatchara C; Srita A; Masurin S; Meeart P; Chueakong W
    PLoS One; 2024; 19(7):e0305918. PubMed ID: 39012925
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Qualitative exploration of perceived benefits of care and barriers influencing HIV care in trans Nzoia, Kenya.
    Naanyu V; Ruff J; Goodrich S; Spira T; Bateganya M; Toroitich-Ruto C; Otieno-Nyunya B; Siika AM; Wools-Kaloustian K
    BMC Health Serv Res; 2020 Apr; 20(1):355. PubMed ID: 32334601
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient experiences of ART adherence clubs in Khayelitsha and Gugulethu, Cape Town, South Africa: A qualitative study.
    Venables E; Towriss C; Rini Z; Nxiba X; Cassidy T; Tutu S; Grimsrud A; Myer L; Wilkinson L
    PLoS One; 2019; 14(6):e0218340. PubMed ID: 31220116
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability.
    Mcinziba A; Wademan D; Viljoen L; Myburgh H; Jennings L; Decloedt E; Orrell C; van Zyl G; van Schalkwyk M; Gandhi M; Hoddinott G
    AIDS Care; 2023 Oct; 35(10):1628-1634. PubMed ID: 36781407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "The sky is the limit": adhering to antiretroviral therapy and HIV self-management from the perspectives of adolescents living with HIV and their adult caregivers.
    Denison JA; Banda H; Dennis AC; Packer C; Nyambe N; Stalter RM; Mwansa JK; Katayamoyo P; McCarraher DR
    J Int AIDS Soc; 2015; 18(1):19358. PubMed ID: 25591915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Stigma trajectories among people living with HIV (PLHIV) embarking on a life time journey with antiretroviral drugs in Jinja, Uganda.
    Mbonye M; Nakamanya S; Birungi J; King R; Seeley J; Jaffar S
    BMC Public Health; 2013 Sep; 13():804. PubMed ID: 24010761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Medication adherence in pregnant women with human immunodeficiency virus receiving antiretroviral therapy in sub-Saharan Africa: a systematic review.
    Omonaiye O; Kusljic S; Nicholson P; Manias E
    BMC Public Health; 2018 Jun; 18(1):805. PubMed ID: 29945601
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV Stigma, HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania.
    Saleem HT; Knight D; Yang C; Kidorf M; Latkin C; Nkya IH
    AIDS Care; 2023 Jan; 35(1):91-94. PubMed ID: 35109727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Perceived risks and amelioration of harm in research using mobile technology to support antiretroviral therapy adherence in the context of methamphetamine use: a focus group study among minorities living with HIV.
    Pasipanodya EC; Kohli M; Fisher CB; Moore DJ; Curtis B
    Harm Reduct J; 2020 Jun; 17(1):41. PubMed ID: 32527276
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 'HIV is like a tsotsi. ARVs are your guns': associations between HIV-disclosure and adherence to antiretroviral treatment among adolescents in South Africa.
    Cluver LD; Hodes RJ; Toska E; Kidia KK; Orkin FM; Sherr L; Meinck F
    AIDS; 2015 Jun; 29 Suppl 1():S57-65. PubMed ID: 26049539
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Perspectives on long-acting injectable HIV antiretroviral therapy at an alternative care site: a qualitative study of people with HIV experiencing substance use and/or housing instability.
    Fletcher L; Burrowes SAB; Khan GK; Sabin L; Johnson S; Kimmel SD; Ruiz-Mercado G; Pierre C; Drainoni ML
    Harm Reduct J; 2023 Jan; 20(1):4. PubMed ID: 36627679
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Understanding reasons for treatment interruption amongst patients on antiretroviral therapy--a qualitative study at the Lighthouse Clinic, Lilongwe, Malawi.
    Tabatabai J; Namakhoma I; Tweya H; Phiri S; Schnitzler P; Neuhann F
    Glob Health Action; 2014; 7():24795. PubMed ID: 25280736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.